News | July 26, 2023
Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
The OMRON Healthcare factory will be built over 6.02 acres and will be manufacturing blood pressure monitors and supplying them mainly to the domestic market.
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Apollo continues to invest in genomics technology and research for better patient care
Getinge has a strong market share in India within several product segments
The facility has been set up to manufacture tuberculosis testing cartridges
Subscribe To Our Newsletter & Stay Updated
